Powered by
ANN ARBOR—Esperion Therapeutics Inc. reported a 150 percent increase in sales for its new cholesterol-lowering drug between the third quarter and the fourth quarter ended Dec. 31. Overall, the company …
NORTHVILLE — Gentherm Inc. (Nasdaq: THRM), the Northville-based thermal management technology developer, reported net income of $27.7 million or 76 cents a share in the third quarter, up from $17.3 …
PLYMOUTH — Rofin-Sinar Technologies Inc. (Nasdaq: RSTI), the industrial laser maker with dual headquarters in Plymouth and in Hamburg, Germany, reported net income of $8.7 million or 31 cents a share in …